Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Context and Ethics

CJ Carlos Antonio Godoy Junior
FM Francesco Miele
LM Laura Mäkitie
EF Eleonora Fiorenzato
MK Maija Koivu
LB Lytske Jantien Bakker
CG Carin Uyl-de Groot
WR William Ken Redekop
WD Welmoed Kirsten van Deen
ask Ask a question
Favorite

The study sites were chosen for their role in the AICCELERATE project [28], a large European Union (EU)-funded collaboration aimed at advancing AI healthcare solutions. One of the use cases within this consortium is an AI-assisted remote monitoring system to track and predict the progression of PD. This system is currently under development and testing at Helsinki University Hospital (HUS) in Finland, and at the University of Padua (UNIPD) in Italy, the two sites included in the current study.

The study was conducted according to the principles of the Declaration of Helsinki and in accordance with the Medical Research Involving Human Subjects Act (WMO) and was approved by the local ethics committees at HUS, UNIPD, and Erasmus University Rotterdam. An informed consent was obtained from all interviewees before participation. Participation was voluntary and no material incentive was given.

Copyright and License information: The Author(s) ©2024
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A